225 related articles for article (PubMed ID: 32619820)
1. Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review.
Zhang H; Liu Q
Transl Oncol; 2020 Oct; 13(10):100812. PubMed ID: 32619820
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the management of gastrointestinal stromal tumor.
Ahmed M
World J Clin Cases; 2020 Aug; 8(15):3142-3155. PubMed ID: 32874969
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress.
Duan Y; Haybaeck J; Yang Z
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066449
[TBL] [Abstract][Full Text] [Related]
4. New advances in radiomics of gastrointestinal stromal tumors.
Cannella R; La Grutta L; Midiri M; Bartolotta TV
World J Gastroenterol; 2020 Aug; 26(32):4729-4738. PubMed ID: 32921953
[TBL] [Abstract][Full Text] [Related]
5. The management of metastatic GIST: current standard and investigational therapeutics.
Kelly CM; Gutierrez Sainz L; Chi P
J Hematol Oncol; 2021 Jan; 14(1):2. PubMed ID: 33402214
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules.
Vallilas C; Sarantis P; Kyriazoglou A; Koustas E; Theocharis S; Papavassiliou AG; Karamouzis MV
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419029
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, diagnosis, and treatment of primary hepatic gastrointestinal stromal tumors.
Qian XH; Yan YC; Gao BQ; Wang WL
World J Gastroenterol; 2020 Oct; 26(40):6195-6206. PubMed ID: 33177793
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
[No Abstract] [Full Text] [Related]
9. MRI Texture-Based Models for Predicting Mitotic Index and Risk Classification of Gastrointestinal Stromal Tumors.
Yang L; Zheng T; Dong Y; Wang Z; Liu D; Du J; Wu S; Shi Q; Liu L
J Magn Reson Imaging; 2021 Apr; 53(4):1054-1065. PubMed ID: 33037745
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.
Lin Y; Wang M; Jia J; Wan W; Wang T; Yang W; Li C; Chen X; Cao H; Zhang P; Tao K
EBioMedicine; 2020 Oct; 60():103016. PubMed ID: 32980695
[TBL] [Abstract][Full Text] [Related]
11. Systemic therapy of advanced/metastatic gastrointestinal stromal tumors: an update on progress beyond imatinib, sunitinib, and regorafenib.
Mohammadi M; Gelderblom H
Expert Opin Investig Drugs; 2021 Feb; 30(2):143-152. PubMed ID: 33252274
[No Abstract] [Full Text] [Related]
12. Update on Molecular Genetics of Gastrointestinal Stromal Tumors.
Brčić I; Argyropoulos A; Liegl-Atzwanger B
Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525726
[TBL] [Abstract][Full Text] [Related]
13. Non-Coding RNAs, a Novel Paradigm for the Management of Gastrointestinal Stromal Tumors.
Amirnasr A; Sleijfer S; Wiemer EAC
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32972022
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment.
Boilève A; Dufresne A; Chamseddine A; Nassif E; Dumont S; Brahmi M; Adam J; Rouleau E; Karanian M; Haddad V; Faron M; Honoré C; Meeus P; Le Cesne A; Blay JY; Mir O
ESMO Open; 2020 Nov; 5(6):e001082. PubMed ID: 33246932
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumours.
Blay JY; Kang YK; Nishida T; von Mehren M
Nat Rev Dis Primers; 2021 Mar; 7(1):22. PubMed ID: 33737510
[TBL] [Abstract][Full Text] [Related]
16. Solitary peritoneal metastasis of gastrointestinal stromal tumor: A case report.
Sugiyama Y; Shimbara K; Sasaki M; Kouyama M; Tazaki T; Takahashi S; Nakamitsu A
World J Gastroenterol; 2020 Sep; 26(36):5527-5533. PubMed ID: 33024403
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of prognostic factors affecting the recurrence and disease-free survival following surgical management of gastrointestinal stromal tumors.
Şenol K; Dağlar Özdemir G; Akat AZ; Kama NA
Turk J Surg; 2020 Jun; 36(2):209-217. PubMed ID: 33015566
[TBL] [Abstract][Full Text] [Related]
18. Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study.
Hu CH; Yeh CN; Chen JS; Tsai CY; Wang SY; Cheng CT; Yeh TS
Oncol Lett; 2020 Sep; 20(3):2131-2142. PubMed ID: 32782530
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation.
Indio V; Ravegnini G; Astolfi A; Urbini M; Saponara M; De Leo A; Gruppioni E; Tarantino G; Angelini S; Pession A; Pantaleo MA; Nannini M
Front Immunol; 2020; 11():851. PubMed ID: 32670260
[TBL] [Abstract][Full Text] [Related]
20. Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes.
Fudalej MM; Badowska-Kozakiewicz AM
Oncol Lett; 2021 May; 21(5):417. PubMed ID: 33841578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
